Grant: Doctoral Research Award: Canada Graduate Scholarships
University of Toronto
$105,000.00
Perfusion Imaging of the Human Brain Using Endogenous Deoxyhemoglobin
EF 2023-24
Résumé
Dynamic susceptibility contrast (DSC) is an MRI-based perfusion imaging method used for a variety of clinical applications, including stroke assessment, brain tumour characterization, and treatment response monitoring. DSC has traditionally relied on the intravenous injection of gadolinium (Gd), a magnetic contrast agent, which can then be tracked with MRI to reveal the underlying perfusion properties of the tissue being imaged. However, Gd is invasive, and recent evidence has shown that it is toxic to patients with kidney disease, accumulates in the brain and bones, and is damaging to aquatic ecosystems. Like Gd, hemoglobin, the oxygen-carrying protein in our blood cells, is magnetic in its deoxygenated state (dOHb). With this in mind, my goal is to harness dOHb as a safe contrast agent alternative in perfusion imaging by developing novel techniques and analysis methods. My project is separated into four aims. First, I have developed a simulation framework to study the theoretical basis of dOHb, in comparison to Gd, and to determine optimal perfusion imaging parameters. Second, I used a gas control system to safely generate dOHb contrast in healthy subjects and compared the perfusion results with those obtained using Gd contrast. Third, I am currently developing a breath-hold approach to induce changes in dOHb without the requirement of additional gas control equipment; I have validated the breath-hold paradigm in healthy subjects and aim to translate the method to patients with glioblastoma. Finally, I aim to develop a framework to isolate perfusion-based signal fluctuations in healthy participants at rest, which can then be used to study perfusion without requiring subject compliance. In sum, the outcomes of this work are expected to provide clinicians and researchers with valuable tools to investigate neurological diseases using a safe and cost-effective perfusion imaging alternative to Gd.
Programme
Doctoral Research Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
496535
Name
Schulman Jacob B
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Perfusion Imaging of the Human Brain Using Endogenous Deoxyhemoglobin
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Cancer; Contrast; Deoxyhemoglobin; Dsc; Gadolinium; Imaging; Mri; Perfusion; Simulations; Stroke
Abstract
Dynamic susceptibility contrast (DSC) is an MRI-based perfusion imaging method used for a variety of clinical applications, including stroke assessment, brain tumour characterization, and treatment response monitoring. DSC has traditionally relied on the intravenous injection of gadolinium (Gd), a magnetic contrast agent, which can then be tracked with MRI to reveal the underlying perfusion properties of the tissue being imaged. However, Gd is invasive, and recent evidence has shown that it is toxic to patients with kidney disease, accumulates in the brain and bones, and is damaging to aquatic ecosystems. Like Gd, hemoglobin, the oxygen-carrying protein in our blood cells, is magnetic in its deoxygenated state (dOHb). With this in mind, my goal is to harness dOHb as a safe contrast agent alternative in perfusion imaging by developing novel techniques and analysis methods. My project is separated into four aims. First, I have developed a simulation framework to study the theoretical basis of dOHb, in comparison to Gd, and to determine optimal perfusion imaging parameters. Second, I used a gas control system to safely generate dOHb contrast in healthy subjects and compared the perfusion results with those obtained using Gd contrast. Third, I am currently developing a breath-hold approach to induce changes in dOHb without the requirement of additional gas control equipment; I have validated the breath-hold paradigm in healthy subjects and aim to translate the method to patients with glioblastoma. Finally, I aim to develop a framework to isolate perfusion-based signal fluctuations in healthy participants at rest, which can then be used to study perfusion without requiring subject compliance. In sum, the outcomes of this work are expected to provide clinicians and researchers with valuable tools to investigate neurological diseases using a safe and cost-effective perfusion imaging alternative to Gd.
Competitiondate
202311
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Schulman, Jacob B
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~